USA - NASDAQ:DLHC - US23335Q1004 - Common Stock
The current stock price of DLHC is 5.85 USD. In the past month the price increased by 2.99%. In the past year, price decreased by -31.42%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ADP | AUTOMATIC DATA PROCESSING | 24.51 | 100.89B | ||
| PAYX | PAYCHEX INC | 21.52 | 39.03B | ||
| DAY | DAYFORCE INC | 31.88 | 10.87B | ||
| PAYC | PAYCOM SOFTWARE INC | 17.53 | 9.00B | ||
| PCTY | PAYLOCITY HOLDING CORP | 19.83 | 7.94B | ||
| KFY | KORN FERRY | 12.44 | 3.28B | ||
| TNET | TRINET GROUP INC | 11.7 | 2.67B | ||
| RHI | ROBERT HALF INC | 16.72 | 2.62B | ||
| UPWK | UPWORK INC | 12.71 | 2.28B | ||
| FA | FIRST ADVANTAGE CORP | 13.86 | 2.22B | ||
| MAN | MANPOWERGROUP INC | 8.67 | 1.23B | ||
| NSP | INSPERITY INC | 19.32 | 1.22B |
DLH Holdings Corp. engages in the provision of technology enabled business process outsourcing program management solutions and public health research and analytics. The company is headquartered in Atlanta, Georgia and currently employs 2,800 full-time employees. The firm is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The firm's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.
DLH HOLDINGS CORP
3565 Piedmont Road, Ne, Building 3, Suite 700
Atlanta GEORGIA 30305 US
CEO: Zachary C. Parker
Employees: 2800
Phone: 18669521647
DLH Holdings Corp. engages in the provision of technology enabled business process outsourcing program management solutions and public health research and analytics. The company is headquartered in Atlanta, Georgia and currently employs 2,800 full-time employees. The firm is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The firm's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, modeling, simulation & training, technology-enabled health solutions, software development, and robotics and unmanned systems.
The current stock price of DLHC is 5.85 USD. The price decreased by -0.17% in the last trading session.
DLHC does not pay a dividend.
DLHC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DLHC.
DLH HOLDINGS CORP (DLHC) will report earnings on 2025-12-08, after the market close.
You can find the ownership structure of DLH HOLDINGS CORP (DLHC) on the Ownership tab.
ChartMill assigns a technical rating of 3 / 10 to DLHC. When comparing the yearly performance of all stocks, DLHC is a bad performer in the overall market: 73.97% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to DLHC. DLHC has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months DLHC reported a non-GAAP Earnings per Share(EPS) of 0.32. The EPS decreased by -37.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.27% | ||
| ROA | 1.53% | ||
| ROE | 4.03% | ||
| Debt/Equity | 1.09 |
7 analysts have analysed DLHC and the average price target is 10.2 USD. This implies a price increase of 74.36% is expected in the next year compared to the current price of 5.85.
For the next year, analysts expect an EPS growth of -66% and a revenue growth -13.41% for DLHC